Practical explainer · Sleep research
Melatonin for Sleep: What Does the Research Show?
Melatonin can help some people sleep, but the research does not support treating it as a universal answer to restless nights. The benefit depends on the sleep problem, the preparation being studied, and when it is taken. Evidence for certain body-clock problems is more encouraging than evidence for routine treatment of chronic insomnia. [1, 3, 5]
That distinction matters. Trouble sleeping after a long flight, a consistently delayed sleep schedule, and months of lying awake are different situations. A product marketed simply “for sleep” can make those differences easy to overlook.
A hormone and a supplement are different things
The body produces melatonin in response to darkness. It helps signal biological night and coordinate the roughly 24-hour sleep-wake rhythm. Light at night can suppress its production. Supplemental melatonin supplies an outside source, usually made synthetically, rather than simply turning up the body’s own production. [1]
A natural role in sleep regulation does not establish that taking extra melatonin will solve every sleep complaint. Research must test the supplement itself against a comparison treatment, in people with a defined problem. The useful question is therefore more specific than “Does melatonin work?” It is “For which condition, under what conditions, and with what trade-offs?”
For chronic insomnia, the evidence is limited
Some trials have found benefits. A 2007 randomized, placebo-controlled study of 170 adults aged 55 or older found improvements in reported sleep quality and morning alertness after three weeks of prolonged-release melatonin. That finding applies to a particular formulation and population; it cannot automatically be extended to younger adults or every gummy, tablet, and liquid on the shelf. [2]
Looking across the evidence, the American Academy of Sleep Medicine’s 2017 pharmacologic guideline made a weak recommendation against using melatonin for adult sleep-onset or sleep-maintenance insomnia. Its assessment relied on a limited evidence base, including studies in older adults, and rated the overall evidence very low quality. A weak recommendation against use is not proof that nobody benefits. It means the evidence did not convincingly establish a clinically meaningful benefit for routine use. [3]
The practical interpretation is modest expectations, not a blanket dismissal. Differences in age, formulation, timing, outcomes, and study duration make sweeping claims difficult. Feeling sleepier also should not be confused with reliably sleeping longer, waking less often, or functioning better the next day. [2, 3]
Body-clock problems are a different use case
Delayed sleep-wake phase disorder involves a persistent mismatch between a person’s sleep timing and the schedule they need to follow. The AASM’s 2015 circadian-rhythm guideline weakly supports strategically timed melatonin for adults with this disorder, with or without depression. This is a condition-specific recommendation, not advice for everyone who occasionally stays up late. [5]
A 2018 randomized trial provides a useful example. Researchers assigned 116 people with clinically diagnosed delayed sleep-wake phase disorder and a confirmed delayed melatonin rhythm to melatonin or placebo, alongside behavioral sleep-wake scheduling. Over four weeks, objectively measured sleep onset occurred about 34 minutes earlier with melatonin relative to placebo, after accounting for baseline. Sleep-related impairment also improved. [6]
The trial did not establish long-term benefits or safety, and its findings may not apply to people whose symptoms occur without the same biological timing delay. The treatment also included a scheduled bedtime, so the result should not be presented as proof that an unscheduled supplement alone will have the same effect. [6]
Jet lag is another setting where melatonin may help. Travel across time zones disrupts the relationship between local time and the body clock. However, the timing needed for travel is not interchangeable with treatment for delayed sleep timing or insomnia. A clinician can help interpret timing in relation to the particular problem; a larger amount is not a substitute for an appropriate plan. [1, 5]
Safety includes the contents of the bottle
Short-term melatonin use appears reasonably well tolerated by many adults, but sleepiness, headache, dizziness, and nausea can occur. Daytime drowsiness matters for driving and other tasks requiring alertness. Evidence about long-term safety remains incomplete. People taking medicines should review possible interactions with a clinician or pharmacist; NCCIH specifically flags medical supervision for people taking blood thinners or living with epilepsy. Pregnancy and breastfeeding safety are insufficiently studied. [1]
Children should not be treated as smaller adults or given melatonin as a routine bedtime shortcut. The AASM advises discussing use with a pediatric health professional first and keeping supplements out of children’s reach. [7]
Product quality adds another uncertainty. A 2017 laboratory study found substantial label discrepancies and detected serotonin in eight tested supplements. A separate 2023 analysis found that 22 of 25 U.S. melatonin gummy products were inaccurately labeled. Among products containing detectable melatonin, amounts ranged from 74% to 347% of the labeled quantity. The latter study detected no serotonin. These were samples of products, not evidence that every brand is contaminated or mislabeled. [8, 9]
In the United States, dietary supplements are regulated differently from medicines. FDA does not approve them for safety and effectiveness before sale. That does not mean supplements are entirely unregulated, but shelf availability should not be mistaken for premarket approval. [10]
What deserves priority?
For chronic insomnia, cognitive behavioral therapy for insomnia, or CBT-I, is a first-line treatment. The AASM’s 2021 guideline strongly recommends multicomponent CBT-I, which addresses sleep-related behaviors and thinking patterns. It is more than a list of sleep-hygiene tips; the guideline advises against using sleep hygiene alone as treatment. [3, 4]
Melatonin has a place in sleep research and in selected clinical situations. The strongest takeaway is to match the approach to the problem, rather than assume that more melatonin means better sleep. Persistent difficulty sleeping deserves assessment and an evidence-based plan, whether or not that plan includes a supplement.
This article is educational and is not a diagnosis or personalized treatment recommendation.